RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
14.91
-0.78 (-4.97%)
At close: Jun 11, 2025, 4:00 PM
14.87
-0.04 (-0.27%)
Pre-market: Jun 12, 2025, 7:17 AM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $605.90 million as of June 12, 2025. Its market cap has decreased by -74.58% in one year.
Market Cap
605.90M
Enterprise Value
388.60M
1-Year Change
-74.58%
Ranking
Category
Stock Price
$14.91
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $605.90M, an increase of 42.79%. That is a compound annual growth rate of 9.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 605.90M | -56.27% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.89B |
| Johnson & Johnson | 375.08B |
| AbbVie | 334.98B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.13B |
| Abbott Laboratories | 232.72B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.45B |